Market Closed -
Nasdaq
04:00:00 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
8.34
USD
|
-0.60%
|
|
+5.84%
|
-3.14%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,633
|
2,202
|
1,628
|
1,595
|
-
|
-
|
Enterprise Value (EV)
1 |
2,317
|
1,954
|
1,587
|
1,575
|
1,577
|
1,524
|
P/E ratio
|
-12.3
x
|
-14.2
x
|
-10.9
x
|
-12.2
x
|
-15.7
x
|
-20.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.25
x
|
1.54
x
|
0.89
x
|
0.63
x
|
0.52
x
|
0.42
x
|
EV / Revenue
|
1.98
x
|
1.36
x
|
0.87
x
|
0.62
x
|
0.51
x
|
0.4
x
|
EV / EBITDA
|
-70
x
|
-73.1
x
|
-44.9
x
|
-1,049
x
|
38.4
x
|
22.4
x
|
EV / FCF
|
-
|
-28.2
x
|
-16.7
x
|
-39.5
x
|
-113
x
|
-94.1
x
|
FCF Yield
|
-
|
-3.54%
|
-6%
|
-2.53%
|
-0.88%
|
-1.06%
|
Price to Book
|
-
|
9.25
x
|
10.2
x
|
14.1
x
|
15.7
x
|
14
x
|
Nbr of stocks (in thousands)
|
187,242
|
187,261
|
189,100
|
191,198
|
-
|
-
|
Reference price
2 |
14.06
|
11.76
|
8.610
|
8.340
|
8.340
|
8.340
|
Announcement Date
|
3/3/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
959.2
|
1,168
|
1,434
|
1,824
|
2,523
|
3,086
|
3,763
|
EBITDA
1 |
-
|
-33.12
|
-26.72
|
-35.32
|
-1.501
|
41.11
|
68.11
|
EBIT
1 |
-
|
-49.15
|
-44.2
|
-56.99
|
-25.22
|
20.06
|
39.37
|
Operating Margin
|
-
|
-4.21%
|
-3.08%
|
-3.12%
|
-1%
|
0.65%
|
1.05%
|
Earnings before Tax (EBT)
1 |
-
|
-195.3
|
-149.3
|
-148.2
|
-127.5
|
-102.8
|
-89.82
|
Net income
1 |
-
|
-195.3
|
-149.5
|
-148
|
-128.7
|
-99.13
|
-78.24
|
Net margin
|
-
|
-16.72%
|
-10.43%
|
-8.12%
|
-5.1%
|
-3.21%
|
-2.08%
|
EPS
2 |
-36.92
|
-1.140
|
-0.8300
|
-0.7900
|
-0.6849
|
-0.5318
|
-0.4028
|
Free Cash Flow
1 |
-
|
-
|
-69.2
|
-95.18
|
-39.9
|
-13.95
|
-16.2
|
FCF margin
|
-
|
-
|
-4.83%
|
-5.22%
|
-1.58%
|
-0.45%
|
-0.43%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/21
|
3/3/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
298.3
|
345.5
|
366.5
|
360.3
|
361.8
|
439.2
|
462.4
|
456.7
|
465.4
|
628.6
|
633.8
|
625.9
|
626.7
|
772.3
|
764.3
|
EBITDA
1 |
-8.872
|
-3.89
|
10.32
|
-9.493
|
-23.65
|
-5.172
|
-2.055
|
-8.42
|
-19.67
|
-11.98
|
3.302
|
11.52
|
-4.231
|
-5.863
|
14.58
|
EBIT
1 |
-13.02
|
-36.48
|
6.14
|
-14.01
|
-28.4
|
-10.15
|
-7.25
|
-13.92
|
-25.53
|
-18.01
|
-1.135
|
4.994
|
-9.869
|
-8.727
|
5.653
|
Operating Margin
|
-4.37%
|
-10.56%
|
1.68%
|
-3.89%
|
-7.85%
|
-2.31%
|
-1.57%
|
-3.05%
|
-5.49%
|
-2.86%
|
-0.18%
|
0.8%
|
-1.57%
|
-1.13%
|
0.74%
|
Earnings before Tax (EBT)
1 |
-47.83
|
-40.82
|
-11.58
|
-40.08
|
-56.82
|
-37.37
|
-28.49
|
-35.08
|
-47.26
|
-46.58
|
-28.92
|
-19.38
|
-35.58
|
-40.66
|
-20.69
|
Net income
1 |
-47.83
|
-40.82
|
-11.58
|
-40.25
|
-56.9
|
-37.28
|
-28.48
|
-35.08
|
-47.21
|
-46.52
|
-26.81
|
-18.85
|
-35.01
|
-39.19
|
-18.57
|
Net margin
|
-16.04%
|
-11.81%
|
-3.16%
|
-11.17%
|
-15.73%
|
-8.49%
|
-6.16%
|
-7.68%
|
-10.14%
|
-7.4%
|
-4.23%
|
-3.01%
|
-5.59%
|
-5.07%
|
-2.43%
|
EPS
2 |
-0.2700
|
-0.2300
|
-0.0600
|
-0.2200
|
-0.3100
|
-0.2000
|
-0.1500
|
-0.1900
|
-0.2500
|
-0.2500
|
-0.1464
|
-0.1081
|
-0.1890
|
-0.2170
|
-0.0932
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/22
|
5/5/22
|
8/4/22
|
11/3/22
|
2/28/23
|
5/4/23
|
8/3/23
|
11/2/23
|
2/27/24
|
5/2/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
316
|
249
|
41.1
|
19.7
|
17.5
|
71
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-69.2
|
-95.2
|
-39.9
|
-14
|
-16.2
|
ROE (net income / shareholders' equity)
|
-
|
-116%
|
-55%
|
-74.9%
|
-101%
|
-100%
|
-90.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-23.6%
|
-24.2%
|
-17.7%
|
-15.1%
|
-
|
Assets
1 |
-
|
-
|
632.4
|
612.9
|
727.2
|
656.5
|
-
|
Book Value Per Share
2 |
-
|
-
|
1.270
|
0.8400
|
0.5900
|
0.5300
|
0.6000
|
Cash Flow per Share
|
-
|
-0.4600
|
-0.2500
|
-0.3200
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
23.8
|
36
|
40.6
|
43
|
50.5
|
Capex / Sales
|
-
|
-
|
1.66%
|
1.97%
|
1.61%
|
1.39%
|
1.34%
|
Announcement Date
|
3/3/21
|
3/3/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
8.34
USD Average target price
8.5
USD Spread / Average Target +1.92% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.14% | 1.59B | | +14.29% | 125B | | +12.91% | 96.05B | | -23.16% | 42.39B | | -5.93% | 37.25B | | -14.32% | 18.14B | | -25.77% | 2.63B | | +15.53% | 546M |
Other Managed Healthcare
|